128 related articles for article (PubMed ID: 10843884)
1. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts.
Sambandam N; Abrahani MA; Craig S; Al-Atar O; Jeon E; Rodrigues B
Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1874-82. PubMed ID: 10843884
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
Niu YG; Evans RD
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
[TBL] [Abstract][Full Text] [Related]
3. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
[TBL] [Abstract][Full Text] [Related]
5. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
7. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats.
Mamo JC; Hirano T; Sainsbury A; Fitzgerald AK; Redgrave TG
Biochim Biophys Acta; 1992 Oct; 1128(2-3):132-8. PubMed ID: 1420285
[TBL] [Abstract][Full Text] [Related]
8. Insulin-mediated modifications of myocardial lipoprotein lipase and lipoprotein metabolism.
O'Looney P; Vander Maten M; Vahouny GV
J Biol Chem; 1983 Nov; 258(21):12994-3001. PubMed ID: 6355100
[TBL] [Abstract][Full Text] [Related]
9. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
10. Lipolysis-induced degradation of apolipoproteins B and E of human very low density lipoproteins.
Chung BH; Im JH; Bowdon HR
J Biol Chem; 1986 Feb; 261(6):2960-7. PubMed ID: 3949755
[TBL] [Abstract][Full Text] [Related]
11. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
Rodrigues B; Spooner M; Severson DL
Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
[TBL] [Abstract][Full Text] [Related]
13. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
Liu L; Severson DL
Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
[TBL] [Abstract][Full Text] [Related]
14. Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase.
de Man FH; de Beer F; van der Laarse A; Smelt AH; Havekes LM
J Lipid Res; 1997 Dec; 38(12):2465-72. PubMed ID: 9458270
[TBL] [Abstract][Full Text] [Related]
15. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
Huff MW; Miller DB; Wolfe BM; Connelly PW; Sawyez CG
J Lipid Res; 1997 Jul; 38(7):1318-33. PubMed ID: 9254059
[TBL] [Abstract][Full Text] [Related]
16. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
Evans AJ; Wolfe BM; Strong WL; Huff MW
Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
[TBL] [Abstract][Full Text] [Related]
17. Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
Niu YG; Evans RD
J Physiol; 2009 Jul; 587(Pt 13):3301-15. PubMed ID: 19433573
[TBL] [Abstract][Full Text] [Related]
18. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
Liu L; Severson DL
Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
[TBL] [Abstract][Full Text] [Related]
19. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes.
O'Looney P; Irwin D; Briscoe P; Vahouny GV
J Biol Chem; 1985 Jan; 260(1):428-32. PubMed ID: 3965456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
